Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Cited by (290)

Items 101–200 of 290

1. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
   Chao Yang, Min Wan, Dengfeng Xu, Da Pan, Hui Xia, Ligang Yang, Guiju Sun · 2021 · International Journal of Molecular Sciences
2. Modulation of the Bile Acid Enterohepatic Cycle by Intestinal Microbiota Alleviates Alcohol Liver Disease
   Dragos Marius Ciocan, Madeleine Spatz, Nicolas Trainel, Kévin Hardonnière, Séverine Domenichini, Françoise Mercier‐Nomé, Aurore Desmons, Lydie Humbert, Sylvère Durand, Guido Kroemer et al. · 2022 · Cells
3. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids
   Grayson W. Way, Kaitlyn G. Jackson, S. Muscu, Huiping Zhou · 2022 · Cells
4. New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease
   Yali Liu, Tao Liu, Xu Min Zhao, Yanhang Gao · 2022 · Cellular and Molecular Life Sciences
5. A perspective of intestinal immune-microbiome interactions in alcohol-associated Liver Disease
   Ryan Bruellman · 2020 · International Journal of Biological Sciences
6. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway
   Chunlin Li, Wenjun Zhou, Meng Li, Xiangbing Shu, Li Rita Zhang, Guang Ji · 2021 · Biomedicine & Pharmacotherapy
7. Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement
   You-Tae Kim, David Andrew Mills · 2024 · Food Science and Biotechnology
8. Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation
   Bojan Stanimirov, Maja Đanić, Nebojša Pavlović, Dragana Zaklan, Slavica Lazarević, Momir Mikov, Karmen Stankov · 2025 · International Journal of Molecular Sciences
9. Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice
   Rongrong Zhou, Cristina Llorente, Jinling Cao, Livia Soares Zaramela, Su-Ling Zeng, Bei Gao, Shang‐Zhen Li, Ryan D. Welch, Feng‐Qing Huang, Lian‐Wen Qi et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
10. Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism
    Meilan Xue, Hui Liang, Zhitong Zhou, Ying Liu, Xinjia He, Zheng Zhang, Ting Sun, Jia Yang, Yimin Qin, Kunpeng Qin · 2021 · Food & Nutrition Research
11. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns
    Oriol Juanola, Mohsin Hassan, Pavitra Kumar, Bahtiyar Yılmaz, Irene Keller, Cédric Simillion, Cornelius Engelmann, Frank Tacke, Jean‐François Dufour, Andrea De Gottardi et al. · 2021 · Gut Microbes
12. Role of Intestinal Microbes in Chronic Liver Diseases
    Mengyi Xu, Kangkang Luo, Junjie Li, Yu Li, Yuxuan Zhang, Zhiyao Yuan, Qiang Xu, Xudong Wu · 2022 · International Journal of Molecular Sciences
13. The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice
    Huikuan Chu, Lu Jiang, Bei Gao, Nagsen Gautam, Jawaher Abdullah Alamoudi, Sonja Lang, Yanhan Wang, Yi Duan, Yazen Alnouti, Edward E. Cable et al. · 2020 · Translational research
14. Host–Microbiota Interactions in Liver Inflammation and Cancer
    Julie Giraud, Maya Saleh · 2021 · Cancers
15. Targeting bile acid signaling for the treatment of liver diseases: From bench to bed
    Shuni Duan, Xiaojiaoyang Li, Guifang Fan, Runping Liu · 2022 · Biomedicine & Pharmacotherapy
16. Mechanisms Underlying Bone Loss Associated with Gut Inflammation
    Ke Ke, Manoj Arra, Yousef Abu‐Amer · 2019 · International Journal of Molecular Sciences
17. Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
    Wen, Yankai, Ma, Lichun, Ju, Cynthia · 2023 · eGastroenterology
18. Akkermansia muciniphila Ameliorates Alcoholic Liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis
    Cheng Fang, Jinyan Cheng, Wei Ping Jia, Yan Xu · 2023 · Metabolites
19. Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease
    Ye Hu, Chao Sun, Ying Chen, Yudong Liu, Jian‐Gao Fan · 2024 · Journal of Clinical and Translational Hepatology
20. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
    Hongshan Li, Yingfei Xi, Hongliang Liu, Xin Xin · 2022 · Frontiers in Nutrition
21. Nuclear receptors and non-alcoholic fatty liver disease: An update
    Yang Xiao, Frank J. Gonzalez, Min Huang, Huichang Bi · 2020 · Liver Research
22. Dexamethasone induces an imbalanced fetal-placental-maternal bile acid circulation: involvement of placental transporters
    Wen Ming Huang, Jin Zhou, Juanjuan Guo, Wen Hu, Guanghui Chen, Bin Li, Yajie Wen, Yimin Jiang, Kaili Fu, Huichang Bi et al. · 2021 · BMC Medicine
23. Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice
    Fei Xiong, Zhongdaixi Zheng, Lingyu Xiao, Chuhong Su, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Huiyu Luo, Longying Zha · 2021 · Molecular Nutrition & Food Research
24. Nigakinone alleviates DSS ‐induced experimental colitis via regulating bile acid profile and FXR / NLRP3 signaling pathways
    Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin · 2022 · Phytotherapy Research
25. Gut microbiota causally affects cholelithiasis: a two-sample Mendelian randomization study
    Xin Liu, Xingsi Qi, Rongshuang Han, Tao Mao, Zibin Tian · 2023 · Frontiers in Cellular and Infection Microbiology
26. Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
    Phillipp Hartmann, Yi Duan, Yukiko Miyamoto, Münevver Demir, Sonja Lang, Elda Hasa, Patrick Stern, Dennis S. Yamashita, Mary Ann Conrad, Lars Eckmann et al. · 2022 · Hepatology International
27. Alcohol and its associated liver carcinogenesis
    Rachael Jacob, David Stephen Prince, Charlotte Kench, Ken Liu · 2023 · Journal of Gastroenterology and Hepatology
28. The gut-liver axis in fatty liver disease: role played by natural products
    Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Xintian Lan · 2024 · Frontiers in Pharmacology
29. Postbiotics Prepared Using Lactobacillus reuteri Ameliorates Ethanol‐Induced Liver Injury by Regulating the FXR/SHP/SREBP‐1c Axis
    Chen Liu, Tianying Cai, Yonglang Cheng, Junjie Bai, Mo Li, Boyuan Gu, Meizhou Huang, Wenguang Fu · 2024 · Molecular Nutrition & Food Research
30. Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR axis
    Renchao Dong, Xiaohui Wang, Lu Wang, Changyuan Wang, Kai Huang, Ting Fu, Kexin Liu, Jingjing Wu, Huijun Sun, Qiang Meng · 2020 · European Journal of Pharmacology
31. Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
    Yiming Yin, Mengge Wang, Wenjie Gu, Lili Chen · 2021 · Biochemical Pharmacology
32. Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease
    Justine Gillard, Isabelle Anne Leclercq · 2023 · Clinical Science
33. Hydrogen Sulfide and Liver Health: Insights into Liver Diseases
    Thuy T. P. Nguyen, Phuc L. Nguyen, So‐Hyun Park, Chang Hwa Jung, Tae–Il Jeon · 2023 · Antioxidants and Redox Signaling
34. FXR Deletion in Hepatocytes does not Affect the Severity of Alcoholic Liver Disease in Mice
    Min Zhang, B. Kong, Ming-Xing Huang, Rui-Xuan Wan, Laura E. Armstrong, Justin D. Schumacher, D. Rizzolo, Monica D. Chow, Yi-Horng Lee, Grace L. Guo · 2018 · Digestive and Liver Disease
35. Gut–liver axis alterations in alcoholic liver disease: Are bile acids the answer?
    Jasmohan Singh Bajaj, Phillip B. Hylemon · 2017 · Hepatology
36. Emerging targets for therapy in ALD: Lessons from NASH
    Ashwani Kumar Singal, Vijay H. Shah, Harmeet Malhi · 2023 · Hepatology
37. Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis
    Zixuan Wang, Xu Wang, Lihong Fu, Shuyang Xu, Xunjiang Wang, Qi Liao, Tongxi Zhuang, Longchan Liu, Haoyue Zhang, Wei Li et al. · 2024 · Phytomedicine
38. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling
    Shengmin Yan, Bilon Khambu, Xiaoyun Chen, Zheng Dong, Grace Liejun Guo, Xiao‐Ming Yin · 2020 · Cellular and Molecular Gastroenterology and Hepatology
39. Gut‐restricted apical sodium‐dependent bile acid transporter inhibitor attenuates alcohol‐induced liver steatosis and injury in mice
    David J. Matye, Yuan Li, Cheng Chen, Xiaojuan Chao, Huaiwen Wang, Hong‐Min Ni, Wen‐Xing Ding, Tiangang Li · 2021 · Alcoholism Clinical and Experimental Research
40. Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
    Chuan Ding, Zeping Wang, Xinyue Dou, Qiao Yang, Yan Ning, Shi Kao, Xianan Sang, Min Hao, Kuilong Wang, Mengyun Peng et al. · 2023 · Aging and Disease
41. Microbial Products and Metabolites Contributing to Alcohol‐Related Liver Disease
    Bei Gao, Atoosa Emami, Shilpa Nath, Bernd Schnabl · 2020 · Molecular Nutrition & Food Research
42. Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction
    Meng Yan, Li Hou, Yaoyao Cai, Hanfei Wang, Yujun Ma, Qiming Geng, Weiwei Jiang, Weibing Tang · 2022 · Frontiers in Pharmacology
43. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
    Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, Su Been Lee, Jin‐Ju Jeong, Haripriya Gupta, Satya Priya Sharma, Ki‐Kwang Oh, Sung‐Min Won, Goo-Hyun Kwon et al. · 2022 · International Journal of Molecular Sciences
44. Bidirectional effects of geniposide in liver injury: Preclinical evidence construction based on meta-analysis
    Xinyu Zeng, Jiajie Jiang, Simiao Liu, Qichao Hu, Sihan Hu, Jinhao Zeng, Xiao Ma, Xiaomei Zhang · 2023 · Journal of Ethnopharmacology
45. Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
    Jorum Kirundi, Sheida Moghadamrad, Camilla Urbaniak · 2023 · World Journal of Gastroenterology
46. Effect of nicotinamide riboside on lipid metabolism and gut microflora‐bile acid axis in alcohol‐exposed mice
    Xiao Yu, Meilan Xue, Ying Liu, Zhitong Zhou, Yushan Jiang, Ting Sun, Hui Wen Liang · 2020 · Food Science & Nutrition
47. Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in rats
    Hanxiang Sun, Xiujuan Su, Yang Liu, Guohua Li, Qiaoling Du · 2023 · iScience
48. A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
    Y. Jiang, Ye-Ming Cao, Yongbing Cao, Tianhua Yan, Chenglin Jia, Ping He · 2024 · Diabetes Metabolic Syndrome and Obesity
49. New insight into intestinal toxicity accelerated by aged microplastics with triclosan: Inflammation regulation by gut microbiota-bile acid axis
    Dawu Lin, Xiangyu Chen, Xiaojun Lin, Chaonan Zhang, Taojie Liang, Li Zheng, Yanbin Xu, Lu Huang, Qingxia Qiao, Kairong Xiong · 2025 · Journal of Hazardous Materials
50. Antarctic krill oil ameliorates liver injury in rats exposed to alcohol by regulating bile acids metabolism and gut microbiota
    Peiyu Guo, Meilan Xue, Xiangyun Teng, Yanhui Wang, Rong Ren, Jianmin Han, Huaqi Zhang, Yingjie Tian, Hui Liang · 2022 · The Journal of Nutritional Biochemistry
51. Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress
    Yadi Zhong, Yingjian Chen, Zhisen Pan, Kaijia Tang, Guangcheng Zhong, Jingyi Guo, Tianqi Cui, Tianyao Li, Siwei Duan, Xiaoying Yang et al. · 2022 · Frontiers in Pharmacology
52. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
    Phillipp Hartmann, Bernd Schnabl · 2021 · Seminars in Liver Disease
53. Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
    Shiv Kumar Sarin, Shvetank Sharma · 2020 · Clinical and Molecular Hepatology
54. Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism
    Justine Gillard, Corinne Picalausa, Christoph Ullmer, Luciano Adorini, Bart Staels, Anne Tailleux, Isabelle Anne Leclercq · 2022 · Nutrients
55. Regulatory mechanisms of the probiotic-targeted gut–liver axis for the alleviation of alcohol-related liver disease: a review
    Feiyu Yang, Xiangfei Li, Jing Yi Sun, Xinyi Pang, Quancai Sun, Yingjian Lu · 2025 · Critical Reviews in Food Science and Nutrition
56. Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice
    Lu Jiang, Huikuan Chu, Bei Gao, Sonja Lang, Yanhan Wang, Yi Duan, Bernd Schnabl · 2020 · Digestive Diseases and Sciences
57. Clostridium Scindens Protects Against Vancomycin‐Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR‐FGF15/19 Signaling
    Jintao Xiao, Yanliang Hou, Xingyang Luo, Yuhao Zhu, Wenhu Li, Bingbing Li, LinXiang Zhou, Xia Chen, Ying Guo, Xiaomei Zhang et al. · 2024 · Advanced Science
58. Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
    Xiaofang Yang, Ming Lü, Lijiao You, Huan Gen, Lin Yuan, Tianning Tian, Chunyu Li, Kailiang Xu, Jie Hou, Ming Lei · 2021 · Chinese Medicine
59. Fibroblast growth factors 19 and 21 in acute liver damage
    Zhao Shan, Gloria Álvarez‐Sola, Iker Uriarte, María Arechederra, Maite G. Fernández‐Barrena, Carmen Berasain, Cynthia Ju, Matias Antonio Avila · 2018 · Annals of Translational Medicine
60. Gut microbiota, bile acids, and nature compounds
    Hao Cheng, Juan Liu, Dandan Zhang, Yuzhu Tan, Wuwen Feng, Cheng Peng · 2022 · Phytotherapy Research
61. Compositional and Metabolomic Shifts of the Gut Microbiome in Alcohol‐Related Liver Disease
    Cheng‐Hao Kuo, Emad M. El-Omar, Cheng‐Yen Kao, Jaw‐Town Lin, Chun‐Ying Wu · 2025 · Journal of Gastroenterology and Hepatology
62. Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein
    Martin J. J. Ronis, Kelly E. Mercer, Kartik Shankar, Casey F. Pulliam, Kim Brint Pedersen, Magnus Ingelman‐Sundberg, Simonetta Friso, Derrick R. Samuelson, Luis Del Valle, Christopher M. Taylor et al. · 2020 · Chemico-Biological Interactions
63. Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases
    Punnag Saha, Phillipp Hartmann · 2025 · Microorganisms
64. Gut microbiome in liver pathophysiology and cholestatic liver disease
    Shengmin Yan, Xiao‐Ming Yin · 2021 · Liver Research
65. Suppression of the gut microbiota–bile acid– FGF19 axis in patients with atrial fibrillation
    Kun Zuo, Fang Chen, Yuanfeng Gao, Yuan Fu, Hongjiang Wang, Jing Li, Jiuchang Zhong, Xinchun Yang, Li Xu · 2023 · Cell Proliferation
66. GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine/A2A pathway
    Chunyan Dong, Bailing Zhou, Binyan Zhao, Ke Lin, Yaomei Tian, Rui Zhang, Daoyuan Xie, Siwen Wu, Li Yang · 2024 · Acta Pharmaceutica Sinica B
67. Microbiota in Alcohol-Associated Organ Damage
    Aenne Harberts, Bernd Schnabl · 2025 · American Journal Of Pathology
68. Altered ethanol metabolism and increased oxidative stress enhance alcohol‐associated liver injury in farnesoid X receptor‐deficient mice
    Caroline Morel, Vivek Chowdhary, Prashanth Thevkar Nagesh, Marcelle de Carvalho Ribeiro, Danielle Hawryluk, Donna E. Catalano, Luciano Adorini, Gyöngyi Szabó · 2022 · Liver International
69. Acetobacter pasteurianus BP2201 alleviates alcohol‐induced hepatic and neuro‐toxicity and modulate gut microbiota in mice
    Xin Wen, Zheng Wang, Qi Liu, Duncan James Lessing, Weihua Chu · 2023 · Microbial Biotechnology
70. Moringa-Fu brick tea extract attenuated high-fat diet-induced obesity via modulating bile acid metabolism and gut microbiota in rats
    Jian Ouyang, Xiuping Li, Changwei Liu, Jie Ou-yang, Jingyi Tang, Qi Liu, Jianan Huang, Zhonghua Liu · 2023 · Journal of Functional Foods
71. Bile Acid Network and Vascular Calcification-Associated Diseases: Unraveling the Intricate Connections and Therapeutic Potential
    Cui Wang, Qing Ma, Xijie Yu · 2023 · Clinical Interventions in Aging
72. Hovenia dulcis Fruit Peduncle Polysaccharides Reduce Intestinal Dysbiosis and Hepatic Fatty Acid Metabolism Disorders in Alcohol-Exposed Mice
    Liangyu Liu, Sijie Zhu, Yuchao Zhang, Zhen‐Yuan Zhu, Yong Xue, Xudong Liu · 2024 · Foods
73. Capsaicin ameliorates cholestasis through modulation of the FXR-SHP and FXR-FGF15 gut-liver axis in mice
    Hui Du, Yue Luo, Ning Zhou, Tong Wang, Ruiyu Wang, Yang Wang, Chuanzhu Lv · 2025 · Phytomedicine
74. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
    Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon · 2026 · Pharmacological Reviews
75. Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease
    Jessica M. Ferrell, Matthew Dilts, Sabita Pokhrel, Zachary Stahl, Shannon Boehme, Xinwen Wang, John Y.L. Chiang · 2024 · Cellular and Molecular Gastroenterology and Hepatology
76. Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights
    Amanda Morrison, Bahaa Elgendy · 2024 · Molecules
77. Analysis of eight bile acids in urine of gastric cancer patients based on covalent organic framework enrichment coupled with liquid chromatography-tandem mass spectrometry
    Jinxiu Lyu, Haijuan Li, Dengyang Yin, Meng Zhao, Qiang Sun, Mengzhe Guo · 2021 · Journal of Chromatography A
78. Water-soluble Poria cocos polysaccharide improves alcoholic liver disease via modulation of gut microbiota-mediated intestinal bile acids-farnesoid X receptor
    Jiajing Huang, Luzhe Yu, Chen Zhang, Yue Fang, Xinyue Zhou, Rulin Wang, Lihua Xing, Lei Wang, Nianjun Yu, Daiyin Peng et al. · 2025 · International Journal of Biological Macromolecules
79. Identification of chikusetsusaponin IVa as a novel lysine-specific demethylase 1 inhibitor that ameliorates high fat diet-induced MASLD in mice
    Yu-wen Liu, Ru-yue Luo, Anqi Liu, Jiawei Wang, Na-ping Hu, Wang-ting Li, Jiankang Li, Jingwen Wang, Jialin Duan · 2024 · Acta Pharmacologica Sinica
80. Gut-muscle axis improves meat quality by regulating energy metabolism
    Haoyu Liu, Lihang He, Ning Ma, Peng Tan, Qi Tang, Kun Cai, Zhaoyue Men, Yutong Lu, Dingyue Hu, Jinshan Zhao et al. · 2026 · Meat Science
81. Review article: insights into the bile acid‐gut microbiota axis in intestinal failure‐associated liver disease—redefining the treatment approach
    Yaoxuan Wang, Lei Zheng, Zhiyuan Zhou, Danhua Yao, Yuhua Huang, Bin Liu, Yantao Duan, Yousheng Li · 2021 · Alimentary Pharmacology & Therapeutics
82. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease
    Bei Gao, Yixin Zhu, Nan Gao, Weishou Shen, Peter Stärkel, Bernd Schnabl · 2021 · Metabolites
83. A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease
    Xiaodong Ge, Hui Han, Romain Désert, Sukanta Das, Zhuolun Song, Sai Santosh Babu Komakula, Wei Chen, Dipti Athavale, Daniel D. Lantvit, Natalia Nieto · 2024 · Cellular and Molecular Gastroenterology and Hepatology
84. Therapeutic manipulation of the microbiome in liver disease
    Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan Singh Bajaj · 2024 · Hepatology
85. Preparation of magnetic mesoporous epoxy resin by initiator-free ring-opening polymerization for extraction of bile acids from human serum
    Lu Sun, Rui Xia Duan, Yu Fan, Xinzhu Chen, Chao Peng, Chao Zheng, Lin‐Yi Dong, Xian-Hua Wang · 2019 · Journal of Chromatography A
86. Current and emerging therapies for alcohol-associated hepatitis
    Francisco Javier Idalsoaga, Gustavo Ayares, Luis Antonio Díaz, Jorge Arnold, María Ayala-Valverde, David Hudson, Marco A. Arrese, Juan Pablo Arab · 2023 · Liver Research
87. Influence of Oral Intaking Habit on Tongue Coating Microbiota in Patients with Esophageal Precancerous Lesions
    Pan Xiao, Zhaolai Hua, Xiaoyu Kang, Bin Lu, Meifeng Li, Juan Wu, Wei Dong, Junfeng Zhang, Chun Cheng · 2022 · Journal of Cancer
88. Inexpensive, Accurate, and Stable Method to Quantitate Blood Alanine Aminotransferase (ALT) Levels
    Phillipp Hartmann, Bernd Schnabl · 2022 · Methods and Protocols
89. Protective effects and mechanism of Sangyu granule on acetaminophen-induced liver injury in mice
    Kexin Xiao, Hongyu Li, Yuening Li, Bo Zhan, Xiaohua Fang, Bingjie Zhao, Xiaofei Zhang, Yumei Wu, Fan Wang, Yanyan Jia · 2024 · Journal of Ethnopharmacology
90. Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota
    Siyuan Sun, Guangheng Zhang, Shimeng Lv, Jinhui Sun · 2024 · Frontiers in Microbiology
91. Microbiome and gut-liver interactions: From mechanisms to therapies
    Muhammad Aarish Anis, Yumna Shahid, Ammara Abdul Majeed, Shahab Abid · 2025 · World Journal of Gastroenterology
92. Bile Acids in Control of the Gut-Liver-Axis
    Benedikt Hild, Hauke Sebastian Heinzow, Hartmut Schmidt, Miriam Maschmeier · 2021 · Zeitschrift für Gastroenterologie
93. The effects, underlying mechanism and interactions of dexamethasone exposure during pregnancy on maternal bile acid metabolism
    Man Fang, Zhang Qi, Pengxia Yu, Caiyun Ge, Juanjuan Guo, Yuanzhen Zhang, Hui Wang · 2020 · Toxicology Letters
94. Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice
    Noemí Cabré, Yi Duan, Cristina Llorente, Mary Ann Conrad, Patrick Stern, Dennis S. Yamashita, Bernd Schnabl · 2021 · Cells
95. Diverse Consequences in Liver Injury in Mice with Different Autophagy Functional Status Treated with Alcohol
    Shengmin Yan, Jun Zhou, Xiaoyun Chen, Zheng Dong, Xiao‐Ming Yin · 2019 · American Journal Of Pathology
96. Emerging Therapies for Alcoholic Hepatitis
    Ma Ai Thanda Han, Nikolaos Pyrsopoulos · 2021 · Clinics in Liver Disease
97. Pasteurized Akkermansia muciniphila and its outer membrane protein Amuc_1100 alleviate alcoholic liver disease through modulating gut microbiota and host metabolism
    Jinyan Cheng, Ziyi Lei, Cheng Fang, Wei Ping Jia, Yan Xu · 2024 · Food Bioscience
98. Gut feeling gone wrong: Tangled relationship between disorders of gut-brain interaction and liver disease
    Manjeet Kumar Goyal, Prerna Goyal, Omesh Goyal, Ajit Sood · 2025 · World Journal of Hepatology
99. Disruption of Bile Acid Metabolism in the Gut–Liver Axis Predisposes Mice to Inflammatory Bowel Disease
    Hui Chang, Yangfu Jiang, Qiong Zhao, Zhen Su, Mingyang Chen, Qiufen He, Jingbo Lai, Yingru Jiang, Jing Zheng, Ruolang Pan et al. · 2025 · MedComm
100. Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR
     Mohammed K. Hankir, Theresa Langseder, Ezgi Eyluel Bankoglu, Yalda Ghoreishi, Ulrich Dischinger, Max Kurlbaum, Matthias Kroiß, Christoph Otto, Carel Wynand le Roux, Tulika Arora et al. · 2020 · iScience